Novartis Investigative Site

Yinchuan, The Ningxia Hui Autonomous Reg 750000

0 studies enrolling now · 2 studies all time

What they study most

Sjogren Syndrome, Sjogrens Syndrome

Studies at this site

• A Randomized, Double-blind 2-arm, Followed by an Open-label 1-arm, NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome. — Running, not enrolling
• Three-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome — Running, not enrolling